HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 46 | 51 | 90.2% | |
| HF004 | 2020 | 57 | 60 | 95.0% | |
| HF006 | 2021 | 100 | 107 | 93.5% | |
| HF006 | 2022 | 109 | 116 | 94.0% | |
| HF006 | 2023 | 126 | 131 | 96.2% |
